Pete Chan, Head of Research and Analysis - Raremark

Pete Chan, head of research & analysis, is responsible for authoring publications based on data and insights derived from Raremark’s patient communities. Pete has previously served as an editor for the pharmaceutical industry’s news and analysis service Scrip Intelligence.

Julie Walters, Founder - Raremark

Julie Walters is the driving force behind Raremark. She has a first-class degree in molecular genetics from King’s College London and a background in popular journalism, before combining her skills to drive change in health. She is an entrepreneur by nature and believes in harnessing the power of families affected by rare disease. She is the winner of multiple awards, including Female Entrepreneur of the Year at the UK’s 2017 Enterprise Awards. Outside Raremark, Julie serves as a trustee of the rare disease patient group www.findacure.org.uk